Literature DB >> 9916929

Expression of inducible nitric oxide synthase in human granulomas and histiocytic reactions.

F Facchetti1, W Vermi, S Fiorentini, M Chilosi, A Caruso, M Duse, L D Notarangelo, R Badolato.   

Abstract

Inducible nitric oxide synthase (iNOS) is required in immune response against infections and is involved in granuloma formation in animals; in murine macrophages, iNOS is induced by lipopolysaccharide and interferon-gamma. In contrast, the role of iNOS in human immune response against infections is still questioned, and its expression in granulomas is poorly investigated. Using Western blotting and immunohistochemistry, we investigated iNOS expression in human lymph nodes with nonspecific reactions and in tissues containing granulomas caused by mycobacteria, Toxoplasma, Cryptococcus neoformans, Leishmania, Bartonella, noninfectious granulomas (sarcoidosis, foreign body), and other hystiocitic reactions (Kikuchi's disease, Omenn syndrome). iNOS was undetectable in nonspecific reactive lymphadenitis, foreign-body granulomas, and Omenn syndrome, whereas it was strongly expressed in infectious granulomas, sarcoidosis, and Kikuchi's diseases. Immunohistochemistry demonstrated that iNOS was selectively expressed by the epithelioid and multinucleated giant cells within the granulomas. Use of an anti-nitrotyrosine antibody, recognizing nitrosilated amino acid residues derived from nitric oxide production, revealed a consistent positivity within the cells expressing iNOS, thus suggesting that iNOS is functionally active. Detection of cytokines by reverse transcriptase-polymerase chain reaction demonstrated that tissues that were positive for iNOS, also expressed the Thl-type cytokine interferon-gamma mRNA, but not the Th2-type cytokine interleukin-4. Taken together, these results indicate that iNOS is involved in different human immune reactions characterized by histiocytic/granulomatous inflammation and associated with Th1-type cytokine secretion.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 9916929      PMCID: PMC1853434          DOI: 10.1016/S0002-9440(10)65261-3

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  54 in total

1.  Cytokine patterns of immunologically mediated tissue damage.

Authors:  M Yamamura; X H Wang; J D Ohmen; K Uyemura; T H Rea; B R Bloom; R L Modlin
Journal:  J Immunol       Date:  1992-08-15       Impact factor: 5.422

2.  IL-10 synergizes with IL-4 and transforming growth factor-beta to inhibit macrophage cytotoxic activity.

Authors:  I P Oswald; R T Gazzinelli; A Sher; S L James
Journal:  J Immunol       Date:  1992-06-01       Impact factor: 5.422

3.  Human mononuclear phagocyte inducible nitric oxide synthase (iNOS): analysis of iNOS mRNA, iNOS protein, biopterin, and nitric oxide production by blood monocytes and peritoneal macrophages.

Authors:  J B Weinberg; M A Misukonis; P J Shami; S N Mason; D L Sauls; W A Dittman; E R Wood; G K Smith; B McDonald; K E Bachus
Journal:  Blood       Date:  1995-08-01       Impact factor: 22.113

4.  Exogenous nitric oxide regulates IFN-gamma plus lipopolysaccharide-induced nitric oxide synthase expression in mouse macrophages.

Authors:  L A Sheffler; D A Wink; G Melillo; G W Cox
Journal:  J Immunol       Date:  1995-07-15       Impact factor: 5.422

5.  Peroxynitrite oxidation of sulfhydryls. The cytotoxic potential of superoxide and nitric oxide.

Authors:  R Radi; J S Beckman; K M Bush; B A Freeman
Journal:  J Biol Chem       Date:  1991-03-05       Impact factor: 5.157

6.  Tumor necrosis factor-alpha-dependent production of reactive nitrogen intermediates mediates IFN-gamma plus IL-2-induced murine macrophage tumoricidal activity.

Authors:  G W Cox; G Melillo; U Chattopadhyay; D Mullet; R H Fertel; L Varesio
Journal:  J Immunol       Date:  1992-11-15       Impact factor: 5.422

7.  Altered responses to bacterial infection and endotoxic shock in mice lacking inducible nitric oxide synthase.

Authors:  J D MacMicking; C Nathan; G Hom; N Chartrain; D S Fletcher; M Trumbauer; K Stevens; Q W Xie; K Sokol; N Hutchinson
Journal:  Cell       Date:  1995-05-19       Impact factor: 41.582

8.  Altered immune responses in mice lacking inducible nitric oxide synthase.

Authors:  X Q Wei; I G Charles; A Smith; J Ure; G J Feng; F P Huang; D Xu; W Muller; S Moncada; F Y Liew
Journal:  Nature       Date:  1995-06-01       Impact factor: 49.962

9.  A hypoxia-responsive element mediates a novel pathway of activation of the inducible nitric oxide synthase promoter.

Authors:  G Melillo; T Musso; A Sica; L S Taylor; G W Cox; L Varesio
Journal:  J Exp Med       Date:  1995-12-01       Impact factor: 14.307

10.  An essential role for interferon gamma in resistance to Mycobacterium tuberculosis infection.

Authors:  J L Flynn; J Chan; K J Triebold; D K Dalton; T A Stewart; B R Bloom
Journal:  J Exp Med       Date:  1993-12-01       Impact factor: 14.307

View more
  31 in total

1.  Immunomodulatory peptide from cystatin, a natural cysteine protease inhibitor, against leishmaniasis as a model macrophage disease.

Authors:  Snigdha Mukherjee; Anindita Ukil; Pijush K Das
Journal:  Antimicrob Agents Chemother       Date:  2007-03-05       Impact factor: 5.191

Review 2.  Acid resistance in Mycobacterium tuberculosis.

Authors:  Omar H Vandal; Carl F Nathan; Sabine Ehrt
Journal:  J Bacteriol       Date:  2009-05-22       Impact factor: 3.490

3.  Regulation of granuloma fibrosis by nitric oxide during Mycobacterium avium experimental infection.

Authors:  Susana Lousada; Manuela Flórido; Rui Appelberg
Journal:  Int J Exp Pathol       Date:  2006-08       Impact factor: 1.925

4.  Mycobacteria exploit nitric oxide-induced transformation of macrophages into permissive giant cells.

Authors:  Kourosh Gharun; Julia Senges; Maximilian Seidl; Anne Lösslein; Julia Kolter; Florens Lohrmann; Manfred Fliegauf; Magdeldin Elgizouli; Marco Alber; Martina Vavra; Kristina Schachtrup; Anna L Illert; Martine Gilleron; Carsten J Kirschning; Antigoni Triantafyllopoulou; Philipp Henneke
Journal:  EMBO Rep       Date:  2017-11-02       Impact factor: 8.807

5.  Laccase protects Cryptococcus neoformans from antifungal activity of alveolar macrophages.

Authors:  L Liu; R P Tewari; P R Williamson
Journal:  Infect Immun       Date:  1999-11       Impact factor: 3.441

6.  Interaction of Bartonella henselae with the murine macrophage cell line J774: infection and proinflammatory response.

Authors:  T Musso; R Badolato; D Ravarino; S Stornello; P Panzanelli; C Merlino; D Savoia; R Cavallo; A N Ponzi; M Zucca
Journal:  Infect Immun       Date:  2001-10       Impact factor: 3.441

7.  Aerosolized gamma interferon (IFN-gamma) induces expression of the genes encoding the IFN-gamma-inducible 10-kilodalton protein but not inducible nitric oxide synthase in the lung during tuberculosis.

Authors:  Bindu Raju; Yoshihiko Hoshino; Kenichi Kuwabara; Ilana Belitskaya; Savita Prabhakar; Antony Canova; Jeffrey A Gold; Rany Condos; Richard I Pine; Stuart Brown; William N Rom; Michael D Weiden
Journal:  Infect Immun       Date:  2004-03       Impact factor: 3.441

8.  Mycobacterium tuberculosis expresses methionine sulphoxide reductases A and B that protect from killing by nitrite and hypochlorite.

Authors:  Warren L Lee; Benjamin Gold; Crystal Darby; Nathan Brot; Xiuju Jiang; Luiz Pedro S de Carvalho; Daniel Wellner; Gregory St John; William R Jacobs; Carl Nathan
Journal:  Mol Microbiol       Date:  2009-02       Impact factor: 3.501

Review 9.  Cell-autonomous effector mechanisms against mycobacterium tuberculosis.

Authors:  John D MacMicking
Journal:  Cold Spring Harb Perspect Med       Date:  2014-07-31       Impact factor: 6.915

10.  The role of nitric oxide in mycobacterial infections.

Authors:  Chul-Su Yang; Jae-Min Yuk; Eun-Kyeong Jo
Journal:  Immune Netw       Date:  2009-04-30       Impact factor: 6.303

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.